ConductScience.org, home

Paper36927642

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.

Hellmich B and 26 others. Ann Rheum Dis, 2024. Cited by 603 papers, by iCite.

Cite this record

ConductScience Library. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Papers, record 36927642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36927642

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
PubMed
Journal
Ann Rheum Dis
PubMed
Year
2024
PubMed
Publication types
Systematic Review, Journal Article
PubMed
Citations, by iCite
603
iCite
Relative citation ratio, by iCite
139.66, provisional
iCite
Revised in PubMed
2025-02-14
PubMed

Authors27

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hellmich BBernhardhttps://orcid.org/0000-0002-8014-1801
2Sanchez-Alamo BBeatriz
3Schirmer JHJan H
4Berti AAlvisehttps://orcid.org/0000-0002-7831-921X
5Blockmans DDaniel
6Cid MCMaria Chttps://orcid.org/0000-0002-4730-0938
7Holle JUJulia U
8Hollinger NNicole
9Karadag OOmer
10Kronbichler AAndreas
11Little MAMark A
12Luqmani RARaashid A
13Mahr AAlfred
14Merkel PAPeter Ahttps://orcid.org/0000-0001-9284-7345
15Mohammad AJAladdin Jhttps://orcid.org/0000-0002-7169-6936
16Monti SSarahttps://orcid.org/0000-0002-1800-6772
17Mukhtyar CBChetan Bhttps://orcid.org/0000-0002-9771-6667
18Musial JJacek
19Price-Kuehne FFiona
20Segelmark MMårten

Source PubMed

See all 27 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMajor topic
Granulomatosis with PolyangiitisMajor topic
Microscopic PolyangiitisMajor topic
Humans
Antibodies, Antineutrophil Cytoplasmic
Azathioprine
Cyclophosphamide
Remission Induction
Rituximab
Practice Guidelines as Topic

Source PubMed

Download CSV of topics

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT06226662Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)BackgroundClinicalTrials.gov
NCT06590545Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA VasculitisResultsClinicalTrials.gov
NCT06611696Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated VasculitisResultsClinicalTrials.gov
NCT07815886Benralizumab Effectiveness in EGPAResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in38040572Reply.https://conductscience.org/library/papers/38040572

Source PubMed

Download CSV of comments and corrections

Cited by446

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 603 citations.

PMIDTitleJournalYearIn PapersSource
42979116Eosinophils in autoimmune diseases: context-dependent pathogenesis, functional heterogeneity, and therapeutic translation.Front Immunol2026https://conductscience.org/library/papers/42979116PubMed
42975756Low-dose IL-2 therapy in autoimmune diseases: mechanisms, clinical evidence, and future strategies for precision immune regulation.Clin Rev Allergy Immunol2026https://conductscience.org/library/papers/42975756PubMed
42963439Association between baseline systemic immune-inflammation index and subsequent stroke in ANCA-associated vasculitis.Clin Rheumatol2026https://conductscience.org/library/papers/42963439PubMed
42957252Hepatobiliary Adverse Events Associated With Avacopan: Analysis of the JADER Database.In Vivo2026https://conductscience.org/library/papers/42957252PubMed
42944789Baseline neutrophil-to-HDL cholesterol ratio is associated with subsequent cerebrovascular accident in patients with microscopic polyangiitis or granulomatosis with polyangiitis.Clin Rheumatol2026https://conductscience.org/library/papers/42944789PubMed
42924604Inflammatory regulatory mechanisms and targeted therapy of antineutrophil cytoplasmic antibodies in atherosclerosis (Review).Int J Mol Med2026https://conductscience.org/library/papers/42924604PubMed
42909277A critical appraisal of guidelines and recommendations for the management of ANCA-associated vasculitis.Clin Kidney J2026https://conductscience.org/library/papers/42909277PubMed
42898620Early recognition of eosinophilic granulomatosis with polyangiitis in outpatient settings: musculoskeletal and gastrointestinal clues beyond respiratory disease.Front Immunol2026https://conductscience.org/library/papers/42898620PubMed
42898067Phenotypic characterization of patients with ANCA-associated vasculitis and diffuse alveolar hemorrhage: a data-driven analysis of a multicentre, retrospective, nationwide cohort.Ann Intensive Care2026https://conductscience.org/library/papers/42898067PubMed
42890987Isolated Acute Tubulointerstitial Nephritis in a Myeloperoxidase-ANCA-Positive Patient Without Crescentic Glomerulonephritis.Cureus2026https://conductscience.org/library/papers/42890987PubMed
42882256Prostatic Involvement in Granulomatosis with Polyangiitis: A Case Report and Scoping Review.Diagnostics (Basel)2026https://conductscience.org/library/papers/42882256PubMed
42876531Anti-interferon-γ autoantibodies: immunopathogenesis, diagnostic innovation, and emerging therapeutic strategies in an adult-onset immunodeficiency.Front Immunol2026https://conductscience.org/library/papers/42876531PubMed
42872282Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody Vasculitis With Isolated Renal Presentation in an Older Female Patient: A Diagnostic and Therapeutic Challenge.J Med Cases2026https://conductscience.org/library/papers/42872282PubMed
42857311Early experience of avacopan for ANCA-associated vasculitis in an Australian paediatric population: a case series.EULAR Rheumatol Open2026https://conductscience.org/library/papers/42857311PubMed
42844361Next-generation immune cell engagers for B cell depletion in autoimmune diseases.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42844361PubMed
42824523Life-Threatening Eosinophilic Granulomatosis With Polyangiitis During Omalizumab Therapy for Chronic Urticaria: Missed Diagnosis, Induction, or Unmasking?Cureus2026https://conductscience.org/library/papers/42824523PubMed
42806340Identification of clinical-biological endophenotypes in patients with eosinophilic granulomatosis with polyangiitis using unsupervised machine learning: a real-world study.Respir Res2026https://conductscience.org/library/papers/42806340PubMed
42797375Effectiveness and Safety of Rituximab in Patients with Refractory Juvenile Idiopathic Arthritis: A Tertiary Center Experience.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797375PubMed
42796306Association Between Any Circulating ANCA Positivity at Diagnosis and Subsequent End-Stage Kidney Disease in Microscopic Polyangiitis and Granulomatosis with Polyangiitis.Medicina (Kaunas)2026https://conductscience.org/library/papers/42796306PubMed
42780982
Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient With Metastatic Renal Cell Carcinoma and Limited Renal Reserve: A Diagnostic Challenge.
Cureus2026https://conductscience.org/library/papers/42780982PubMed

See all 446 cited byDownload CSV of cited by

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
RITUXIMABCHEMBL1201576Results1https://conductscience.org/library/drugs/CHEMBL1201576ChEMBL
AVACOPANCHEMBL3989871Results1https://conductscience.org/library/drugs/CHEMBL3989871ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36927642

GET https://conductscience.org/api/papers/v1/36927642/authors?page=2